Dual-acting therapeutic proteins for intraocular use

• Dual acting therapeutic proteins may be a better strategy than drug combinations for treatment of chronic retinal diseases. • Several targets to treat neovascularisation and inflammation have been identified. • A dual acting molecule to increase the duration of action in the vitreous has potential for treatment of chronic retinal diseases. • The key challenge in developing intraocular medicines is ensuring there is minimal ocular toxicity. •...